Literature DB >> 22468904

Effect of formulation compositions on niosomal preparations.

Cheng Shu Chaw1, Kwong Yioung Ah Kim.   

Abstract

This study was aimed to investigate the effects of molar ratio of cholesterol to Span 60 and stabilizers (Solutol HS 15 or dicetyl phosphate (DCP)) on the entrapment of methylene blue, a model hydrophilic drug. The niosomes were prepared by the film hydration method and characterized for drug entrapment efficiency (EE), vesicle size, zeta potential and thermal properties of niosomal membrane. It was found that niosomal vesicles possessed median diameter ranging from 0.35 to 1.85 μm. The niosomes that were formulated with lower molar ratios of cholesterol to Span 60 of 0.33 and 0.50 produced significantly higher EE with both stabilizers when compared to cholesterol to Span 60 molar ratios of 1.0 and above (p < 0.05). The EE of niosomes stabilized with DCP was significantly higher (p < 0.05) than those prepared with Solutol HS 15 except at a molar ratio of cholesterol to Span 60 of 0.33. In conclusion, with low molar ratios of cholesterol to Span 60, more drugs could be entrapped within the niosomes regardless of the type of stabilizers. Furthermore, EE and median diameter of niosomes containing DCP were higher than those stabilized with Solutol HS 15.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22468904     DOI: 10.3109/10837450.2012.672988

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  4 in total

1.  In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug.

Authors:  Akhtar Rasul; Muhammad Imran Khan; Mujeeb Ur Rehman; Ghulam Abbas; Nosheen Aslam; Shabbir Ahmad; Khizar Abbas; Pervaiz Akhtar Shah; Muhammad Iqbal; Ali Mohammad Ahmed Al Subari; Talal Shaheer; Shahid Shah
Journal:  Int J Nanomedicine       Date:  2020-10-14

2.  Hybrid of niosomes and bio-synthesized selenium nanoparticles as a novel approach in drug delivery for cancer treatment.

Authors:  Mahmoud Gharbavi; Behrooz Johari; Navid Mousazadeh; Bahareh Rahimi; Milad Parvinzad Leilan; Seyed Sadegh Eslami; Ali Sharafi
Journal:  Mol Biol Rep       Date:  2020-08-07       Impact factor: 2.316

3.  In vitro and in vivo investigation for optimization of niosomal ability for sustainment and bioavailability enhancement of diltiazem after nasal administration.

Authors:  H O Ammar; M Haider; M Ibrahim; N M El Hoffy
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 4.  Proniosomes derived niosomes: recent advancements in drug delivery and targeting.

Authors:  Maryam Khatoon; Kifayat Ullah Shah; Fakhar Ud Din; Shefaat Ullah Shah; Asim Ur Rehman; Naz Dilawar; Ahmad Nawaz Khan
Journal:  Drug Deliv       Date:  2017       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.